Joan Chypyha

Joan Chypyha

Director/Board Member at OVATION SCIENCE INC.

Net worth: 7 236 $ as of 2026-06-29

60 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Joan Chypyha is the founder of Alto Pharmaceuticals Ltd., founded in 2008, serving as President & Chief Executive Officer.
Current jobs include Independent Director at Ovation Science, Inc. (Canada) since 2018 and Independent Director at Edesa Biotech, Inc. since 2023.
Former jobs include Director at Canadian Healthcare Licensing Association, President at Cipher Pharmaceuticals, Inc. from 2013 to 2017, Chief Business Development Officer at Rhei Pharmaceuticals Ltd. from 2009 to 2011, VP-Corporate Development & General Manager at Barrier Therapeutics Canada, Inc. from 2004 to 2008, and President at Canadian Dermatology Association from 2015 to 2023.
Education includes an MBA from Queen's University and an undergraduate degree from the University of Toronto.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-10-19 200,000 ( 0.52% ) 7 000 $ 2026-06-29
2026-05-26 29 ( 0% ) 236 $ 2026-06-29

Joan Chypyha active positions

CompaniesPositionStart
OVATION SCIENCE INC. Director/Board Member 2018-02-01
EDESA BIOTECH, INC. Director/Board Member 2023-05-22
Chief Executive Officer 2007-12-31

Former positions of Joan Chypyha

CompaniesPositionEnd
President 2022-12-31
CIPHER PHARMACEUTICALS INC. President 2017-06-01
Rhei Pharmaceuticals Ltd.
Corporate Officer/Principal 2010-12-31
Barrier Therapeutics Canada, Inc.
Corporate Officer/Principal 2008-07-31
Canadian Healthcare Licensing Association
Director/Board Member -
See the detail of Joan Chypyha's experience

Training of Joan Chypyha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Consumer Services

Canadian Healthcare Licensing Association

Health Technology

Consumer Non-Durables

Rhei Pharmaceuticals Ltd.

Barrier Therapeutics Canada, Inc.

Health Technology

Commercial Services